Tech Company M&A Transactions

Proteolix Acquisition

Based in South San Francisco, Proteolix was acquired by Onyx Pharmaceuticals. The transaction price was $850 million.

Transaction Overview

Company Name
Announced On
Transaction Type
M&A Terms
Under the terms of the transaction, Onyx will make a $276 million cash payment upon closing of the transaction. Additional payments include $40 million payable in 2010 based on the achievement of a development milestone and up to $535 million contingent upon the achievement of anticipated approvals for carfilzomib in the U.S. and Europe. Of the potential $535 million, a payment of $170 million is based upon the achievement of accelerated U.S. Food and Drug Administration approval. The transaction is expected to close in the fourth quarter of 2009, subject to the receipt of clearance under the Hart-Scott-Rodino Act and customary closing conditions.

Company Information

Company Status
Acquired or Merged
Mailing Address
333 Allerton Avenue
South San Francisco, CA 94080
Email Address
Proteolix, Inc. is a biopharmaceutical company dedicated to discovering, developing and marketing pharmaceutical products that target the proteasome and the control of protein turnover in cells. The company's focus is on the treatment of cancer, inflammatory disease, and autoimmunity.
Proteolix LinkedIn Company Profile
Social Media
Proteolix Company Twitter Account
Company News
Proteolix News
Proteolix on Facebook
Proteolix on YouTube

Management Team

Email & Social
Chief Medical Officer
Michael Kauffman
  Michael Kauffman LinkedIn Profile  Michael Kauffman Twitter Account  Michael Kauffman News  Michael Kauffman on Facebook
Executive Vice President
Thomas Kassberg
  Thomas Kassberg LinkedIn Profile  Thomas Kassberg Twitter Account  Thomas Kassberg News  Thomas Kassberg on Facebook
Vice President
Mark Bennett
  Mark Bennett LinkedIn Profile  Mark Bennett Twitter Account  Mark Bennett News  Mark Bennett on Facebook
Vice President
Christopher Molineaux
  Christopher Molineaux LinkedIn Profile  Christopher Molineaux Twitter Account  Christopher Molineaux News  Christopher Molineaux on Facebook
VP - Finance
Craig Parker
  Craig Parker LinkedIn Profile  Craig Parker Twitter Account  Craig Parker News  Craig Parker on Facebook
VP - Regulatory Affairs
Albert Kraus
  Albert Kraus LinkedIn Profile  Albert Kraus Twitter Account  Albert Kraus News  Albert Kraus on Facebook



Browse more venture capital transactions:

Prev: 10/12/2009: Brilliant Telecommunications venture capital transaction
Next: 10/13/2009: Transactiv venture capital transaction


Share this article


About Database of VC Transactions

We report on all VC transactions involving tech companies. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary